Jonathan Young
2022
In 2022, Jonathan Young earned a total compensation of $4.1M as Chief Operating Officer at Akero Therapeutics, a 131% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $314,300 |
|---|---|
| Option Awards | $2,556,818 |
| Salary | $449,000 |
| Stock Awards | $824,425 |
| Total | $4,144,543 |
Young received $2.6M in option awards, accounting for 62% of the total pay in 2022.
Young also received $314.3K in non-equity incentive plan, $449K in salary and $824.4K in stock awards.
Rankings
In 2022, Jonathan Young's compensation ranked 831st out of 5,744 executives tracked by ExecPay. In other words, Young earned more than 85.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 831 out of 5,744 | 86th |
Division Manufacturing | 379 out of 3,128 | 88th |
Major group Chemicals And Allied Products | 129 out of 1,416 | 91st |
Industry group Drugs | 116 out of 1,317 | 91st |
Industry Pharmaceutical Preparations | 87 out of 963 | 91st |
Pay ratio
| Jonathan Young's Pay | $4,144,543 |
|---|---|
| Median Employee's Pay | $515,516 |
| Pay Ratio | 8to 1 |
In 2022, the annual total compensation of Jonathan Young was $4,144,543.
The annual total compensation of the median employee at Akero Therapeutics was $515,516.
The ratio of Jonathan Young's pay to the pay of median employee was therefore 8 to one.
Source: SEC filing on April 28, 2023.
Young's colleagues
We found four more compensation records of executives who worked with Jonathan Young at Akero Therapeutics in 2022.